Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?

The main purpose of this study is to evaluate the presence of viral RNA of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) in conjunctival swab specimen of coronavirus disease 2019 (COVID‐19) patients with and without conjunctivitis to establish the diagnostic value of reverse transcrip...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical virology 2021-01, Vol.93 (1), p.383-388
Hauptverfasser: Güemes‐Villahoz, Noemi, Burgos‐Blasco, Barbara, Arribi‐Vilela, Ana, Arriola‐Villalobos, Pedro, Rico‐Luna, Carla M., Cuiña‐Sardiña, Ricardo, Delgado‐Iribarren, Alberto, García‐Feijoó, Julián
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 388
container_issue 1
container_start_page 383
container_title Journal of medical virology
container_volume 93
creator Güemes‐Villahoz, Noemi
Burgos‐Blasco, Barbara
Arribi‐Vilela, Ana
Arriola‐Villalobos, Pedro
Rico‐Luna, Carla M.
Cuiña‐Sardiña, Ricardo
Delgado‐Iribarren, Alberto
García‐Feijoó, Julián
description The main purpose of this study is to evaluate the presence of viral RNA of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) in conjunctival swab specimen of coronavirus disease 2019 (COVID‐19) patients with and without conjunctivitis to establish the diagnostic value of reverse transcription‐polymerase chain reaction (RT‐PCR) in each case and to describe its clinical characteristics. A cross‐sectional study was conducted at the Hospital Clinico San Carlos of Madrid, Spain. Thirty‐six subjects from the COVID admission unit with laboratory‐confirmed SARS‐CoV‐2 infection were included. Conjunctival swabs were collected from 18 patients with conjunctivitis and 18 patients without conjunctivitis and RT‐PCR was performed. Conjunctival swab was collected from both eyes of 36 patients (72 eyes), detecting SARS‐CoV‐2 RNA in conjunctival swab of two patients (5.5%). Among the 18 patients with conjunctivitis, only one of them (5.5%) showed positive results. Likewise, SARS‐CoV‐2 RNA was detected in one patient without conjunctivitis (5.5%). The mean age of the 36 patients was 67.9 years (range, 28‐92 years) and the male‐to‐female ratio was 0.44 (16:20). The mean days since the onset of COVID‐19 symptoms until conjunctivitis manifestation was 8 (range, 1‐24 days). The mean duration of the conjunctivitis was 3 days (range, 1‐7 days). SARS‐CoV‐2 RNA may be detected in conjunctival swabs of both patients with and without conjunctivitis. This study revealed the same rate of positive results amongst the group with and without conjunctivitis, suggesting that detecting SARS‐CoV‐2 in ocular fluids is not conditioned on the presence of conjunctivitis. The presence of SARS‐CoV‐2 RNA in ocular samples highlights the role of the eye as a possible route of transmission of the disease. Highlights SARS‐CoV‐2 RNA can be detected in conjunctival secretions of both patients with and without conjunctivitis. However, PCR essay of tears and conjunctival secretions appear to have a fairly low potential of detecting the virus.
doi_str_mv 10.1002/jmv.26219
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7361904</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2416931420</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5419-e9ec922a068040a5c060bb15c5bcbd11f979a972c2d4eda93fc61e75d0577ce53</originalsourceid><addsrcrecordid>eNp1kc1u1DAURi0EotPCghdAltjAIu21EztjFkWjKT-DCpVamK3lODdTR4ld4mSq7ngEnpEnwTClAiQ219L10dF39RHyhMEhA-BHbb895JIzdY_MGCiZKSjZfTIDVshMSib2yH6MLQDMFecPyV7ORam4kDPSnuCIdnR-Qy8W5xffv35bhnWanJ5_XFDnqQ2-nXwitqajEe2Aows-vqSrSN1IDU37yVQd0tqZjQ9xdJb2OF6GmoaGLs_Wq5PkY-rVI_KgMV3Ex7fvAfn85vWn5bvs9Oztark4zawomMpQoU0pDcg5FGCEBQlVxYQVla1qxhpVKqNKbnldYG1U3ljJsBQ1iLK0KPIDcrzzXk1Vj7VFPw6m01eD681wo4Nx-u8f7y71Jmx1mUumoEiC57eCIXyZMI66d9Fi1xmPYYqaF0yqnBUcEvrsH7QN0-DTeYkq8yKXuZon6sWOskOIccDmLgwD_bNBnRrUvxpM7NM_09-RvytLwNEOuHYd3vzfpN9_WO-UPwAigac7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2473436398</pqid></control><display><type>article</type><title>Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Güemes‐Villahoz, Noemi ; Burgos‐Blasco, Barbara ; Arribi‐Vilela, Ana ; Arriola‐Villalobos, Pedro ; Rico‐Luna, Carla M. ; Cuiña‐Sardiña, Ricardo ; Delgado‐Iribarren, Alberto ; García‐Feijoó, Julián</creator><creatorcontrib>Güemes‐Villahoz, Noemi ; Burgos‐Blasco, Barbara ; Arribi‐Vilela, Ana ; Arriola‐Villalobos, Pedro ; Rico‐Luna, Carla M. ; Cuiña‐Sardiña, Ricardo ; Delgado‐Iribarren, Alberto ; García‐Feijoó, Julián</creatorcontrib><description>The main purpose of this study is to evaluate the presence of viral RNA of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) in conjunctival swab specimen of coronavirus disease 2019 (COVID‐19) patients with and without conjunctivitis to establish the diagnostic value of reverse transcription‐polymerase chain reaction (RT‐PCR) in each case and to describe its clinical characteristics. A cross‐sectional study was conducted at the Hospital Clinico San Carlos of Madrid, Spain. Thirty‐six subjects from the COVID admission unit with laboratory‐confirmed SARS‐CoV‐2 infection were included. Conjunctival swabs were collected from 18 patients with conjunctivitis and 18 patients without conjunctivitis and RT‐PCR was performed. Conjunctival swab was collected from both eyes of 36 patients (72 eyes), detecting SARS‐CoV‐2 RNA in conjunctival swab of two patients (5.5%). Among the 18 patients with conjunctivitis, only one of them (5.5%) showed positive results. Likewise, SARS‐CoV‐2 RNA was detected in one patient without conjunctivitis (5.5%). The mean age of the 36 patients was 67.9 years (range, 28‐92 years) and the male‐to‐female ratio was 0.44 (16:20). The mean days since the onset of COVID‐19 symptoms until conjunctivitis manifestation was 8 (range, 1‐24 days). The mean duration of the conjunctivitis was 3 days (range, 1‐7 days). SARS‐CoV‐2 RNA may be detected in conjunctival swabs of both patients with and without conjunctivitis. This study revealed the same rate of positive results amongst the group with and without conjunctivitis, suggesting that detecting SARS‐CoV‐2 in ocular fluids is not conditioned on the presence of conjunctivitis. The presence of SARS‐CoV‐2 RNA in ocular samples highlights the role of the eye as a possible route of transmission of the disease. Highlights SARS‐CoV‐2 RNA can be detected in conjunctival secretions of both patients with and without conjunctivitis. However, PCR essay of tears and conjunctival secretions appear to have a fairly low potential of detecting the virus.</description><identifier>ISSN: 0146-6615</identifier><identifier>EISSN: 1096-9071</identifier><identifier>DOI: 10.1002/jmv.26219</identifier><identifier>PMID: 32579256</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Bodily Secretions - virology ; Conjunctiva - chemistry ; Conjunctivitis ; Conjunctivitis, Viral - physiopathology ; Coronaviridae ; coronavirus ; Coronaviruses ; COVID ; COVID-19 ; COVID-19 - diagnosis ; COVID-19 - virology ; Cross-Sectional Studies ; diagnosis ; Diagnostic systems ; Disease transmission ; Eye ; Eye (anatomy) ; Female ; Humans ; Male ; Middle Aged ; Patients ; PCR ; Polymerase chain reaction ; Respiratory diseases ; Reverse transcription ; Ribonucleic acid ; RNA ; RNA, Viral - analysis ; Secretions ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Signs and symptoms ; Spain ; Specimen Handling ; Tears ; Viral diseases ; Virology ; Viruses</subject><ispartof>Journal of medical virology, 2021-01, Vol.93 (1), p.383-388</ispartof><rights>2020 Wiley Periodicals LLC</rights><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5419-e9ec922a068040a5c060bb15c5bcbd11f979a972c2d4eda93fc61e75d0577ce53</citedby><cites>FETCH-LOGICAL-c5419-e9ec922a068040a5c060bb15c5bcbd11f979a972c2d4eda93fc61e75d0577ce53</cites><orcidid>0000-0003-2178-6164</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjmv.26219$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjmv.26219$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32579256$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Güemes‐Villahoz, Noemi</creatorcontrib><creatorcontrib>Burgos‐Blasco, Barbara</creatorcontrib><creatorcontrib>Arribi‐Vilela, Ana</creatorcontrib><creatorcontrib>Arriola‐Villalobos, Pedro</creatorcontrib><creatorcontrib>Rico‐Luna, Carla M.</creatorcontrib><creatorcontrib>Cuiña‐Sardiña, Ricardo</creatorcontrib><creatorcontrib>Delgado‐Iribarren, Alberto</creatorcontrib><creatorcontrib>García‐Feijoó, Julián</creatorcontrib><title>Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?</title><title>Journal of medical virology</title><addtitle>J Med Virol</addtitle><description>The main purpose of this study is to evaluate the presence of viral RNA of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) in conjunctival swab specimen of coronavirus disease 2019 (COVID‐19) patients with and without conjunctivitis to establish the diagnostic value of reverse transcription‐polymerase chain reaction (RT‐PCR) in each case and to describe its clinical characteristics. A cross‐sectional study was conducted at the Hospital Clinico San Carlos of Madrid, Spain. Thirty‐six subjects from the COVID admission unit with laboratory‐confirmed SARS‐CoV‐2 infection were included. Conjunctival swabs were collected from 18 patients with conjunctivitis and 18 patients without conjunctivitis and RT‐PCR was performed. Conjunctival swab was collected from both eyes of 36 patients (72 eyes), detecting SARS‐CoV‐2 RNA in conjunctival swab of two patients (5.5%). Among the 18 patients with conjunctivitis, only one of them (5.5%) showed positive results. Likewise, SARS‐CoV‐2 RNA was detected in one patient without conjunctivitis (5.5%). The mean age of the 36 patients was 67.9 years (range, 28‐92 years) and the male‐to‐female ratio was 0.44 (16:20). The mean days since the onset of COVID‐19 symptoms until conjunctivitis manifestation was 8 (range, 1‐24 days). The mean duration of the conjunctivitis was 3 days (range, 1‐7 days). SARS‐CoV‐2 RNA may be detected in conjunctival swabs of both patients with and without conjunctivitis. This study revealed the same rate of positive results amongst the group with and without conjunctivitis, suggesting that detecting SARS‐CoV‐2 in ocular fluids is not conditioned on the presence of conjunctivitis. The presence of SARS‐CoV‐2 RNA in ocular samples highlights the role of the eye as a possible route of transmission of the disease. Highlights SARS‐CoV‐2 RNA can be detected in conjunctival secretions of both patients with and without conjunctivitis. However, PCR essay of tears and conjunctival secretions appear to have a fairly low potential of detecting the virus.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Bodily Secretions - virology</subject><subject>Conjunctiva - chemistry</subject><subject>Conjunctivitis</subject><subject>Conjunctivitis, Viral - physiopathology</subject><subject>Coronaviridae</subject><subject>coronavirus</subject><subject>Coronaviruses</subject><subject>COVID</subject><subject>COVID-19</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - virology</subject><subject>Cross-Sectional Studies</subject><subject>diagnosis</subject><subject>Diagnostic systems</subject><subject>Disease transmission</subject><subject>Eye</subject><subject>Eye (anatomy)</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patients</subject><subject>PCR</subject><subject>Polymerase chain reaction</subject><subject>Respiratory diseases</subject><subject>Reverse transcription</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA, Viral - analysis</subject><subject>Secretions</subject><subject>Severe acute respiratory syndrome</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Signs and symptoms</subject><subject>Spain</subject><subject>Specimen Handling</subject><subject>Tears</subject><subject>Viral diseases</subject><subject>Virology</subject><subject>Viruses</subject><issn>0146-6615</issn><issn>1096-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAURi0EotPCghdAltjAIu21EztjFkWjKT-DCpVamK3lODdTR4ld4mSq7ngEnpEnwTClAiQ219L10dF39RHyhMEhA-BHbb895JIzdY_MGCiZKSjZfTIDVshMSib2yH6MLQDMFecPyV7ORam4kDPSnuCIdnR-Qy8W5xffv35bhnWanJ5_XFDnqQ2-nXwitqajEe2Aows-vqSrSN1IDU37yVQd0tqZjQ9xdJb2OF6GmoaGLs_Wq5PkY-rVI_KgMV3Ex7fvAfn85vWn5bvs9Oztark4zawomMpQoU0pDcg5FGCEBQlVxYQVla1qxhpVKqNKbnldYG1U3ljJsBQ1iLK0KPIDcrzzXk1Vj7VFPw6m01eD681wo4Nx-u8f7y71Jmx1mUumoEiC57eCIXyZMI66d9Fi1xmPYYqaF0yqnBUcEvrsH7QN0-DTeYkq8yKXuZon6sWOskOIccDmLgwD_bNBnRrUvxpM7NM_09-RvytLwNEOuHYd3vzfpN9_WO-UPwAigac7</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Güemes‐Villahoz, Noemi</creator><creator>Burgos‐Blasco, Barbara</creator><creator>Arribi‐Vilela, Ana</creator><creator>Arriola‐Villalobos, Pedro</creator><creator>Rico‐Luna, Carla M.</creator><creator>Cuiña‐Sardiña, Ricardo</creator><creator>Delgado‐Iribarren, Alberto</creator><creator>García‐Feijoó, Julián</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2178-6164</orcidid></search><sort><creationdate>202101</creationdate><title>Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?</title><author>Güemes‐Villahoz, Noemi ; Burgos‐Blasco, Barbara ; Arribi‐Vilela, Ana ; Arriola‐Villalobos, Pedro ; Rico‐Luna, Carla M. ; Cuiña‐Sardiña, Ricardo ; Delgado‐Iribarren, Alberto ; García‐Feijoó, Julián</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5419-e9ec922a068040a5c060bb15c5bcbd11f979a972c2d4eda93fc61e75d0577ce53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Bodily Secretions - virology</topic><topic>Conjunctiva - chemistry</topic><topic>Conjunctivitis</topic><topic>Conjunctivitis, Viral - physiopathology</topic><topic>Coronaviridae</topic><topic>coronavirus</topic><topic>Coronaviruses</topic><topic>COVID</topic><topic>COVID-19</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - virology</topic><topic>Cross-Sectional Studies</topic><topic>diagnosis</topic><topic>Diagnostic systems</topic><topic>Disease transmission</topic><topic>Eye</topic><topic>Eye (anatomy)</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patients</topic><topic>PCR</topic><topic>Polymerase chain reaction</topic><topic>Respiratory diseases</topic><topic>Reverse transcription</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA, Viral - analysis</topic><topic>Secretions</topic><topic>Severe acute respiratory syndrome</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Signs and symptoms</topic><topic>Spain</topic><topic>Specimen Handling</topic><topic>Tears</topic><topic>Viral diseases</topic><topic>Virology</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Güemes‐Villahoz, Noemi</creatorcontrib><creatorcontrib>Burgos‐Blasco, Barbara</creatorcontrib><creatorcontrib>Arribi‐Vilela, Ana</creatorcontrib><creatorcontrib>Arriola‐Villalobos, Pedro</creatorcontrib><creatorcontrib>Rico‐Luna, Carla M.</creatorcontrib><creatorcontrib>Cuiña‐Sardiña, Ricardo</creatorcontrib><creatorcontrib>Delgado‐Iribarren, Alberto</creatorcontrib><creatorcontrib>García‐Feijoó, Julián</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Güemes‐Villahoz, Noemi</au><au>Burgos‐Blasco, Barbara</au><au>Arribi‐Vilela, Ana</au><au>Arriola‐Villalobos, Pedro</au><au>Rico‐Luna, Carla M.</au><au>Cuiña‐Sardiña, Ricardo</au><au>Delgado‐Iribarren, Alberto</au><au>García‐Feijoó, Julián</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?</atitle><jtitle>Journal of medical virology</jtitle><addtitle>J Med Virol</addtitle><date>2021-01</date><risdate>2021</risdate><volume>93</volume><issue>1</issue><spage>383</spage><epage>388</epage><pages>383-388</pages><issn>0146-6615</issn><eissn>1096-9071</eissn><abstract>The main purpose of this study is to evaluate the presence of viral RNA of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) in conjunctival swab specimen of coronavirus disease 2019 (COVID‐19) patients with and without conjunctivitis to establish the diagnostic value of reverse transcription‐polymerase chain reaction (RT‐PCR) in each case and to describe its clinical characteristics. A cross‐sectional study was conducted at the Hospital Clinico San Carlos of Madrid, Spain. Thirty‐six subjects from the COVID admission unit with laboratory‐confirmed SARS‐CoV‐2 infection were included. Conjunctival swabs were collected from 18 patients with conjunctivitis and 18 patients without conjunctivitis and RT‐PCR was performed. Conjunctival swab was collected from both eyes of 36 patients (72 eyes), detecting SARS‐CoV‐2 RNA in conjunctival swab of two patients (5.5%). Among the 18 patients with conjunctivitis, only one of them (5.5%) showed positive results. Likewise, SARS‐CoV‐2 RNA was detected in one patient without conjunctivitis (5.5%). The mean age of the 36 patients was 67.9 years (range, 28‐92 years) and the male‐to‐female ratio was 0.44 (16:20). The mean days since the onset of COVID‐19 symptoms until conjunctivitis manifestation was 8 (range, 1‐24 days). The mean duration of the conjunctivitis was 3 days (range, 1‐7 days). SARS‐CoV‐2 RNA may be detected in conjunctival swabs of both patients with and without conjunctivitis. This study revealed the same rate of positive results amongst the group with and without conjunctivitis, suggesting that detecting SARS‐CoV‐2 in ocular fluids is not conditioned on the presence of conjunctivitis. The presence of SARS‐CoV‐2 RNA in ocular samples highlights the role of the eye as a possible route of transmission of the disease. Highlights SARS‐CoV‐2 RNA can be detected in conjunctival secretions of both patients with and without conjunctivitis. However, PCR essay of tears and conjunctival secretions appear to have a fairly low potential of detecting the virus.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32579256</pmid><doi>10.1002/jmv.26219</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-2178-6164</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0146-6615
ispartof Journal of medical virology, 2021-01, Vol.93 (1), p.383-388
issn 0146-6615
1096-9071
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7361904
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Aged
Aged, 80 and over
Bodily Secretions - virology
Conjunctiva - chemistry
Conjunctivitis
Conjunctivitis, Viral - physiopathology
Coronaviridae
coronavirus
Coronaviruses
COVID
COVID-19
COVID-19 - diagnosis
COVID-19 - virology
Cross-Sectional Studies
diagnosis
Diagnostic systems
Disease transmission
Eye
Eye (anatomy)
Female
Humans
Male
Middle Aged
Patients
PCR
Polymerase chain reaction
Respiratory diseases
Reverse transcription
Ribonucleic acid
RNA
RNA, Viral - analysis
Secretions
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Signs and symptoms
Spain
Specimen Handling
Tears
Viral diseases
Virology
Viruses
title Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T00%3A41%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Detecting%20SARS%E2%80%90CoV%E2%80%902%20RNA%20in%20conjunctival%20secretions:%20Is%20it%20a%20valuable%20diagnostic%20method%20of%20COVID%E2%80%9019?&rft.jtitle=Journal%20of%20medical%20virology&rft.au=G%C3%BCemes%E2%80%90Villahoz,%20Noemi&rft.date=2021-01&rft.volume=93&rft.issue=1&rft.spage=383&rft.epage=388&rft.pages=383-388&rft.issn=0146-6615&rft.eissn=1096-9071&rft_id=info:doi/10.1002/jmv.26219&rft_dat=%3Cproquest_pubme%3E2416931420%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2473436398&rft_id=info:pmid/32579256&rfr_iscdi=true